Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Wilson

Showing results (321-330 of 328) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 328 results.
Journal of Medicinal Chemistry|August 15, 2017
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide ScaffoldElena Sandoval, María José Lafuente-Monasterio, María J Almela, et al.
Journal of Medicinal Chemistry|November 23, 2017
Correction to The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide ScaffoldElena Sandoval, María José Lafuente-Monasterio, María J Almela, et al.
Journal of Medicinal Chemistry|July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA CooperativityJames M Smith, Bernard Barlaam, David Beattie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical modelsAndrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and AntagonistJames S Scott, Thomas A Moss, Amber Balazs, et al.
Journal of Medicinal Chemistry|September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human KinomeAvipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry|February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 InhibitorJason D Shields, David Baker, Amber Y S Balazs, et al.
Pageof 33

Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
Journal of Medicinal Chemistry|August 15, 2017
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide ScaffoldElena Sandoval, María José Lafuente-Monasterio, María J Almela, et al.
Journal of Medicinal Chemistry|November 23, 2017
Correction to The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide ScaffoldElena Sandoval, María José Lafuente-Monasterio, María J Almela, et al.
Journal of Medicinal Chemistry|July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA CooperativityJames M Smith, Bernard Barlaam, David Beattie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical modelsAndrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and AntagonistJames S Scott, Thomas A Moss, Amber Balazs, et al.
Journal of Medicinal Chemistry|September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human KinomeAvipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry|February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 InhibitorJason D Shields, David Baker, Amber Y S Balazs, et al.
Pageof 33